7.76
-0.10
(-1.21%)
As of 2:49:31 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BENZENO SHARON Officer | Sale | Mar 5, 2024 | 327,415 |
| BOBULSKY SUSAN Officer | Conversion of Exercise of derivative security | Oct 8, 2024 | 253,290 |
| GRIFFIN MICHELLE RENEE Director | Stock Award(Grant) | Mar 4, 2024 | 51,955 |
| LO FRANCIS Officer | Sale | Mar 5, 2024 | 256,245 |
| NEUPERT PETER M Director | Conversion of Exercise of derivative security | Mar 12, 2024 | 169,296 |
| PETERSON TYCHO Chief Financial Officer | Sale | Mar 5, 2024 | 531,553 |
| PISKEL KYLE Chief Financial Officer | Sale | Nov 18, 2024 | 154,330 |
| ROBINS CHAD M Chief Executive Officer | Sale | Mar 5, 2024 | 2,576,700 |
| RUBINSTEIN JULIAN President | Sale | Mar 5, 2024 | 472,754 |
| TAYLOR STACY L General Counsel | Sale | Aug 22, 2024 | 139,365 |
Related Tickers
BEAM Beam Therapeutics Inc.
26.22
-3.90%
FATE Fate Therapeutics, Inc.
1.3000
-5.11%
VERV Verve Therapeutics, Inc.
7.50
+1.21%
NTLA Intellia Therapeutics, Inc.
10.23
-2.71%
CDXS Codexis, Inc.
4.2600
-5.32%
VIR Vir Biotechnology, Inc.
10.25
-0.63%
EDIT Editas Medicine, Inc.
1.3200
-3.65%
ABSI Absci Corporation
3.6948
-3.28%
CRBU Caribou Biosciences, Inc.
1.4500
+10.69%
COGT Cogent Biosciences, Inc.
9.17
-4.68%